Even if some people from the group defined as those with immunodeficiencies have developed immunity to the coronavirus to some extent, taking the third dose will not harm them, but it will strengthen protection – Prof. Krzysztof Pyrć from the Jagiellonian University, vice-chairman of the interdisciplinary advisory team for COVID-19 at the President of the Polish Academy of Sciences.
And he explained that – of course – it may happen that in a group identified by the Medical Council as a high-risk group, i.e. with immunodeficiency, it may be that someone has developed sufficient and persistent immunity after taking the first full dose of the COVID-19 vaccine. . However, such cases, according to research, are the exception rather than the rule. “Even if that happened, taking a third dose by such a person would not hurt him “- emphasized prof. Krzysztof Pyrć. And he added that the greater risk was not taking an additional dose of the preparation.
Prof. When asked if it was possible that the patient’s immune system was so disturbed that neither the third nor the fourth dose of the vaccine would cause him to develop antibodies against the virus, he replied that there may be a person who simply will not respond to the vaccination. However, the long-standing studies show that a third dose of the vaccine will increase protection against COVID-19 in most of them.
He also admitted that there is not enough research yet to discuss the superiority of specific combinations of vaccines, i.e. it cannot be unequivocally said that a person who was vaccinated with a full dose of preparation X should take preparation Y in the third dose. accepted a single-dose vaccine produced by Johnson & Johnson. In the next phase of vaccination, he should take one dose of a two-dose preparation, such as Pfizer.
- Israel: Ọgwụ ịgba ọgwụ mgbochi nke iri na abụọ maka afọ 12 niile
During Friday’s press conference, Minister of Health Adam Niedzielski presented the position of the Medical Council regarding the third dose. “The Council accepts the admission of the third vaccination for the group of people with impaired immunity, so for now we will dedicate the third dose to people who have impaired immunity” – he handed over.
«The third dose of the vaccine for this group of people should not be considered as a booster. It is supposed to strengthen – and maybe finally induce – the correct immune response. We should remember that this is also the case with vaccinations for other diseases. People who have been cured of cancer – for example children – also undergo the vaccination course again, it is recreated in them »- emphasized in an interview with PAP Prof. dr hab. n. med. Magdalena Marczyńska from the Medical University of Warsaw.
- These diseases require an additional dose of vaccination. Why?
As Minister Niedzielski previously emphasized, “as far as the date of administration of this third dose is concerned, it is established as not earlier than 28 days from the end of the primary vaccination cycle”.
The head of the Ministry of Health added that the qualification for vaccinations is individual. “In the near future. I think we will do it from September 1, these people will be able to have such access »- he said.
"The Medical Council made seven recommendations on immune disorders»- Niedzielski said and mentioned that these are people who: receive active anti-cancer treatment, after transplants, they take immunosuppressive drugs; after a stem cell transplant within the last two years; with moderate or severe primary immunodeficiency syndromes; HIV-infected; taking specialist medications that may suppress the immune response, and patients on dialysis.
“These seven groups were indicated by the Medical Council and they are a recommendation that should always be assessed by the attending physician” – he emphasized.
The group to which the recommendation of the Medical Council applies, according to prof. Marczyńska is 200-400 thousand. Poles.
Prof. Marczyńska admitted that the council also discussed the third dose for people over 70 years of age. «For now, however, we are waiting with a recommendation for all other groups. The position of the European Medicines Agency (EMA) on this issue is to be around September 20 »- she explained. (PAP)
Author: Mira Suchodolska
Ịchọrọ ịnwale mgbochi COVID-19 gị mgbe ịgba ọgwụ mgbochi ahụ gasịrị? Ị butere ọrịa ma chọọ ịlele ọkwa mgbochi gị? Hụ ngwungwu nnwale mgbochi COVID-19, nke ị ga-eme na isi netwọkụ Diagnostics.
Gụọ kwa:
- Ihe mgbochi a na-apụ n'anya na Denmark. Ihe karịrị pasentị 80 n'ime ha agbawo ọgwụ mgbochi. ọha mmadụ
- Ị na-eme atụmatụ ezumike gị nke Septemba? Na mba ndị a, ọrịa na-efe efe anaghị ada mbà
- "N'ihi ọrịa na-efe efe, nwa ahụ nwere ụlọ akwụkwọ na nsọpụrụ. Ọ naghị atụ egwu nje a »[LIST]
- Ọrịa 200 kwa ụbọchị dị ọtụtụ? Fiałek: Ọnọdụ a tụrụ ya n'anya bụ asịrị
Ọdịnaya nke webụsaịtị medTvoiLokony bu n'obi imeziwanye, ọ bụghị dochie anya kọntaktị dị n'etiti Onye ọrụ weebụsaịtị na dọkịta ha. Ezubere webụsaịtị ahụ maka ebumnuche ozi na naanị nkuzi. Tupu ịgbaso ihe ọmụma ọkachamara, karịsịa ndụmọdụ ahụike, dị na weebụsaịtị anyị, ị ga-agarịrị dọkịta. Onye nchịkwa anaghị ebute nsonaazụ ọ bụla sitere na iji ozi dị na weebụsaịtị. Ị chọrọ ndụmọdụ gbasara ahụike ma ọ bụ ndenye ọgwụ e-redee? Gaa na halodoctor.pl, ebe ị ga-enweta enyemaka n'ịntanetị - ngwa ngwa, n'enweghị nsogbu na ịhapụ ụlọ gị.